Artículos por temáticas

Butyrylcholinesterase is associated with β-amyloid plaques in the transgenic APPSWE/PSEN1dE9 mouse model of Alzheimer disease

Darvesh S, Cash MK, Reid GA, Martin E, Mitnitski A, Geula C.

J Neuropathol Exp Neurol. 2012 Jan;71(1):2-14. doi: 10.1097/NEN.0b013e31823cc7a6.

Brain insulin signaling and Alzheimer's disease: current evidence and future directions

Schiöth HB, Craft S, Brooks SJ, Frey WH 2nd, Benedict C.

Mol Neurobiol. 2012 Aug;46(1):4-10. doi: 10.1007/s12035-011-8229-6. Epub 2011 Dec 29.

Enrichment of the inositol 1,4,5-trisphosphate receptor/Ca2+ channels in secretory granules and essential roles of chromogranins

Yoo SH, Hur YS.

Cell Calcium. 2012 Mar-Apr;51(3-4):342-50. doi: 10.1016/j.ceca.2011.12.008. Epub 2012 Jan 3.

The amyloid precursor protein and its homologues: structural and functional aspects of native and pathogenic oligomerization

Kaden D, Munter LM, Reif B, Multhaup G.

Eur J Cell Biol. 2012 Apr;91(4):234-9. doi: 10.1016/j.ejcb.2011.01.017. Epub 2011 Apr 2.

Copper and iron in Alzheimer's disease: a systematic review and its dietary implications

Loef M, Walach H.

Br J Nutr. 2012 Jan;107(1):7-19. doi: 10.1017/S000711451100376X. Epub 2011 Jul 18.

Can cytogenetics explain the possible association between exposure to extreme low-frequency magnetic fields and Alzheimer's disease?

Maes A, Verschaeve L.

J Appl Toxicol. 2012 Feb;32(2):81-7. doi: 10.1002/jat.1724. Epub 2011 Sep 20.

Cell cycle proteins in brain in mild cognitive impairment: insights into progression to Alzheimer disease

Keeney JT, Swomley AM, Harris JL, Fiorini A, Mitov MI, Perluigi M, Sultana R, Butterfield DA.

Neurotox Res. 2012 Oct;22(3):220-30. doi: 10.1007/s12640-011-9287-2. Epub 2011 Nov 15.

Bridging the pathophysiology of Alzheimer's disease with vascular pathology: the feed-back, the feed-forward, and oxidative stress

Polidori MC, Pientka L.

J Alzheimers Dis. 2012;28(1):1-9. doi: 10.3233/JAD-2011-111034.

NCAM2/OCAM/RNCAM: cell adhesion molecule with a role in neuronal compartmentalization

Winther M, Berezin V, Walmod PS.

Int J Biochem Cell Biol. 2012 Mar;44(3):441-6. doi: 10.1016/j.biocel.2011.11.020. Epub 2011 Dec 2.

Metals in Alzheimer's disease: a systemic perspective

Squitti R.

Front Biosci (Landmark Ed). 2012 Jan 1;17(2):451-72. doi: 10.2741/3938.

The potential role of microRNA-146 in Alzheimer's disease: biomarker or therapeutic target?

Wang LL, Huang Y, Wang G, Chen SD.

Med Hypotheses. 2012 Mar;78(3):398-401. doi: 10.1016/j.mehy.2011.11.019. Epub 2011 Dec 29.

Attention-related networks in Alzheimer's disease: a resting functional MRI study

Li R, Wu X, Fleisher AS, Reiman EM, Chen K, Yao L.

Hum Brain Mapp. 2012 May;33(5):1076-88. doi: 10.1002/hbm.21269. Epub 2011 Apr 29.

White matter integrity and vulnerability to Alzheimer's disease: preliminary findings and future directions

Gold BT, Johnson NF, Powell DK, Smith CD.

Biochim Biophys Acta. 2012 Mar;1822(3):416-22. doi: 10.1016/j.bbadis.2011.07.009. Epub 2011 Jul 23.

Takotsubo cardiomyopathy in an elderly patient with severe Alzheimer's disease: a case report

Cerri AP, Teruzzi F, Gregorio M, Bellelli G, Annoni G.

J Am Med Dir Assoc. 2012 Mar;13(3):207-9. doi: 10.1016/j.jamda.2011.09.002. Epub 2011 Oct 12.

National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease: a practical approach

Montine TJ, Phelps CH, Beach TG, Bigio EH, Cairns NJ, Dickson DW, Duyckaerts C, Frosch MP, Masliah E, Mirra SS, Nelson PT, Schneider JA, Thal DR, Trojanowski JQ, Vinters HV, Hyman BT; National Institu

Acta Neuropathol. 2012 Jan;123(1):1-11. doi: 10.1007/s00401-011-0910-3. Epub 2011 Nov 20.